Graft Versus Host Disease.

Graft Versus Host Disease177Flournoy N, Dahlberg S, et al. Prednisone andazathioprine compared with prednisone and placebofor treatment of chronic graft-v-host disease: prognosticinfluence of prolonged thrombocytopenia afterallogeneic marrow transplantation. Blood 1988;72:546-54.30. Gaziev D, Galimberti M, Lucarelli G, Polchi P. Chronicgraft-versus-host disease: is there an alternative to theconventional treatment? Bone Marrow Transplant2000;25:689-96.31. Parker PM, Chao N, Nademanee A, O’Donnell MR,Schmidt GM, Snyder DS, et al. Thalidomide assalvage therapy for chronic graft-versus-host disease.Blood 1995;86:3604-9.32. Kanamaru A, Takemoto Y, Kakishita E, Dohy H, KoderaY, Moriyama Y, et al. FK506 treatment of graft-versushostdisease developing or exacerbating duringprophylaxis and therapy with cyclosporin and/or otherimmunosuppressants. Japanese FK506 BMT StudyGroup. Bone Marrow Transplant 1995;15:885-9.33. Vogelsang GB, Arai S. Mycophenolatemofetilfortheprevention and treatment of graft-versus-host diseasefollowing stem cell transplantation: preliminaryfindings. Bone Marrow Transplant 2001;27:1255-62.วารสารโลหิตวิทยาและเวชศาสตรบริการโลหิต ปที่ 13 ฉบับที่ 2 เมษายน-มิถุนายน 2546